PTC Therapeutics, Inc. (PTCT) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for PTCT. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 13,964,554 | $1.1B | INCREASED |
| Vanguard | 9,386,980 | $766M | INCREASED |
| Rtw Investments | 7,746,415 | $632M | UNCHANGED |
| Jupiter Topco | 7,236,402 | $590M | NEW |
| State Street | 4,598,952 | $375M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Michael Schmertzler (Director) | SELL | 376 | $26K | 2026-09-16 |
| Michael Schmertzler (Director) | SELL | 9,624 | $653K | 2026-09-16 |
| Michael Schmertzler (Director) | SELL | 7,006 | $472K | 2026-09-16 |
| Michael Schmertzler (Director) | SELL | 2,994 | $199K | 2026-09-16 |
| Michael Schmertzler (Director) | SELL | 10,000 | $673K | 2026-09-09 |
Full institutional holdings, insider history, and congressional trades for PTC Therapeutics, Inc. on SentiSense.